Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_assertion type Assertion NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_head.
- NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_provenance.
- NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_assertion evidence source_evidence_literature NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_provenance.
- NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_assertion SIO_000772 15721400 NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_provenance.
- NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_assertion wasDerivedFrom befree-20150227 NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_provenance.
- NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_assertion wasGeneratedBy ECO_0000203 NP358001.RATfLCS2jn81gK27ODayAi5ZHxfDyd2ulEB2bcfbqqtc4130_provenance.